Fig. 3: Kaplan-Meier survival curves. | Nature Communications

Fig. 3: Kaplan-Meier survival curves.

From: Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial

Fig. 3: Kaplan-Meier survival curves.The alternative text for this image may have been generated using AI.

a OS, b EFS and c RFS for treatment-naive and R/R patients. 95% CI, 95% confidence interval of the median; NA, confidence limit could not be determined. p-values from one-tailed log-rank test. Source data are provided as a Source Data file.

Back to article page